InVitria develops, manufactures, and markets recombinant, scalable and sustainable products that improve manufacturing and formulation for cell and gene therapy, vaccines, biopharmaceuticals, CAR T cell therapy, stem cells, medical devices, and regenerative medicines.
Looking for a particular InVitria employee's phone or email?
The InVitria annual revenue was $53 million in 2026.
Marcus Curl is the Vice President, Product Applications of InVitria.
19 people are employed at InVitria.
InVitria is based in Junction City, Kansas.
The NAICS codes for InVitria are [3254, 325, 325414, 32541, 32].
The SIC codes for InVitria are [283, 28].